Dr. Russell Blaylock, M.D. is a nationally recognized board-certified neurosurgeon, health practitioner, author, and lecturer. He attended the Louisiana State University School of Medicine and completed his internship and neurological residency at the Medical University of South Carolina. For 26 years, practiced neurosurgery in addition to having a nutritional practice. He recently retired from his neurosurgical duties to devote his full attention to nutritional research. Dr. Blaylock writes The Blaylock Wellness Report newsletter and has authored four books, Excitotoxins: The Taste That Kills, Health and Nutrition Secrets That Can Save Your Life, Natural Strategies for Cancer Patients, and his most recent work, Cellular and Molecular Biology of Autism Spectrum Disorders.

Dr. Russell Blaylock, M.D.

The Statin Myth — It's Inflammation, Not Cholesterol

Wednesday, 02 Oct 2013 10:27 AM

  Comment  |
   Contact Us  |
|  A   A  
  Copy Shortlink
The dream of all pharmaceutical company CEOs has been to develop a drug that people will need to take for a lifetime in order to control their condition. The cholesterol-lowering statin drugs have fulfilled that dream.
Stain drugs have been the biggest moneymaker in history for the pharmaceutical industry, promoted by both drug companies and physicians. But all is not as it appears.  
Articles touting the advantages of statin drugs have appeared  in the most prestigious medical journals in the world. But some of them have actually been written by scientists employed by pharmaceutical companies.
Amidst all of the positive article and media hoopla, the public has been denied one essential bit of information: The benefits of statin cholesterol-lowering drugs are no better than taking an aspirin a day. (Learn more by reading my special report “5 Breakthrough Medical Updates You Need to Know.”)
In fact, according to the pharmaceutical industry’s own studies, the improvements in
reducing heart attack and stroke risk are virtually the same as following an aspirin regimen.
We also are not being told that the link between elevated cholesterol levels — even LDL-cholesterol — and heart disease, is much weaker than measures of inflammation — especially highly sensitive CRP (hsCRP).
The latest studies show that inflammation is an independent risk factor for heart disease that is much stronger than any measure of cholesterol. A study of two statin drugs, atorvastatin and pravastatin, found that patients with low hsCRP levels had fewer heart attacks no matter their LDLcholesterol level, and they had more heart attacks if their hsCRP was elevated regardless of their LDLcholesterol level. The same thing has been found for stroke risk.
Few physicians who prescribe statin drugs know that the link between elevated cholesterol levels and strokes has never been established, but the link to inflammation is strong and is supported by many laboratory and clinical studies.
Why won’t the drug manufacturers and physicians who promote statin drugs just change their policy and give statin drugs only to people with increased inflammation?
It all comes down to dollars. If I make lowering cholesterol my goal — especially a drastic decrease — I can convince doctors that everyone, even children, should take
them for a lifetime. Yet, if I use hsCRP or other measures of inflammation as the criteria for prescribing statins, the drug would not be given to 75 percent to 80 percent of people presently prescribed to them. That is a massive loss of revenue.
Now that the statin promoters have admitted that inflammation, not elevated cholesterol, is the cause of atherosclerosis, we can examine ways to reduce inflammation in our bodies (and our blood vessels in particular) rather than using statin drugs.
Most chronic diseases and conditions, such as metabolic syndrome and abdominal fat, are associated with chronic inflammation. For more information on how you can boost your health and extend your life by reducing chronic inflammation, go here.
To read more of Dr. Blaylock's weekly tips, go here to view the archive.

© 2014 NewsmaxHealth. All rights reserved.

  Comment  |
   Contact Us  |
  Copy Shortlink
Around the Web
Please review Community Guidelines before posting a comment.
>> Register to share your comments with the community.
>> Login if you are already a member.
blog comments powered by Disqus
Retype Email:
Zip Code:
Privacy: We never share your email.
Find Your Condition
You May Also Like
Around the Web
Most Commented

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, NewsmaxWorld, NewsmaxHealth, are trademarks of Newsmax Media, Inc.

© Newsmax Media, Inc.
All Rights Reserved